Edgewise Therapeutics, Inc.

Q2 2022 13F Holders

Symbol
EWTX
CUSIP
28036F105
Type
Equity
Class
COM
Num filings
79
Total reported value, excl. options
$406 M
Manager Report Date Value ($000) Shares Option Type